The story
Sofwave was established in 2015 by Dr. Shimon Eckhouse (founder and chairman) and Ariel Sverdlik (CTO) in the Alon Medtech Ventures incubator, in Yokneam, Israel, which is part of Israel Innovation Authority.
Eckhouse has been dubbed by the newspapers as the father of the medical aesthetics field in Israel. He invested in and founded dozens of companies,
including Lumenis, that was sold for $1.2 billion,
and Syneron Medical, that reached a market capitalization of $1 billion,
both listed on Nasdaq.
In September 2019, Sofwave Medical Inc. was founded, a subsidiary fully owned by Sofwave. Listed in Delaware, it is the marketing branch of the group in the US.
In 2019, Sofwave raised $8.4 million in funding led by XT Hi-Tech, of Ofer Family
and started selling its product in late 2019.
Read the full text
In May 2021, the company raised $50 million at a pre-money valuation of $192 million in the IPO in the TASE.
The company reported revenues of $21.8 million in 2021, an increase of 408% compared to 2020. The gross income increased from $2.6 million in 2020 to $16.2 million in 2021. In North America, revenues reached $13.5 million, compared to $3.4 million in 2020. The operating loss in 2021 was $8.9 million, compared to $6.6 million in 2020.
From Wikipedia’s article on Sofwave Medical, shared under CC BY-SA 4.0.4